BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $485,190 | -15.4% | 81,000 | 0.0% | 0.15% | -13.9% |
| Q3 2023 | $573,480 | +0.6% | 81,000 | 0.0% | 0.17% | -0.6% |
| Q2 2023 | $570,240 | -15.6% | 81,000 | 0.0% | 0.17% | -17.9% |
| Q1 2023 | $675,540 | -27.4% | 81,000 | 0.0% | 0.21% | -30.5% |
| Q4 2022 | $929,880 | -8.9% | 81,000 | 0.0% | 0.30% | -19.1% |
| Q3 2022 | $1,021,000 | +19.1% | 81,000 | 0.0% | 0.38% | +24.0% |
| Q2 2022 | $857,000 | -34.9% | 81,000 | 0.0% | 0.30% | -26.9% |
| Q1 2022 | $1,317,000 | -13.4% | 81,000 | -19.0% | 0.42% | -12.4% |
| Q4 2021 | $1,521,000 | +5.8% | 100,000 | 0.0% | 0.48% | -1.7% |
| Q3 2021 | $1,437,000 | – | 100,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |